During the past decade, Bangalore Institute of Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bangalore Institute of Oncology" #1 sponsor was "Peregrine Pharmaceuticals" with 2 trials, followed by "Hoffmann-La Roche" with 1 trials sponsored, "Human Genome Sciences Inc." with 1 trials sponsored, "Jazz Pharmaceuticals" with 1 trials sponsored and "Light Sciences Oncology" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bangalore Institute of Oncology" #1 collaborator was "PPD" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Bangalore Institute of Oncology" are "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Cancer" (1 trials), "Colorectal Neoplasms" (1 trials) and "Liver Metastases" (1 trials). Many other conditions were trialed in "Bangalore Institute of Oncology" in a lesser frequency.

Most popular intervention types in "Bangalore Institute of Oncology" are "Drug" (8 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aromatase Inhibitor" (1 trials), "Bortezomib" (1 trials), "Docetaxel plus bavituximab or placebo" (1 trials), "EndoTAG-1" (1 trials) and "EndoTAG-1 + paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bangalore Institute of Oncology" are 6 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Bangalore Institute of Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Bangalore Institute of Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bangalore Institute of Oncology, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".